IL164670A0 - Pharmaceutical compositions containing growth hormone and an insulin sensitizing agent - Google Patents

Pharmaceutical compositions containing growth hormone and an insulin sensitizing agent

Info

Publication number
IL164670A0
IL164670A0 IL16467004A IL16467004A IL164670A0 IL 164670 A0 IL164670 A0 IL 164670A0 IL 16467004 A IL16467004 A IL 16467004A IL 16467004 A IL16467004 A IL 16467004A IL 164670 A0 IL164670 A0 IL 164670A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
growth hormone
sensitizing agent
containing growth
Prior art date
Application number
IL16467004A
Other languages
English (en)
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0209642A external-priority patent/GB0209642D0/en
Priority claimed from GB0218912A external-priority patent/GB0218912D0/en
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Publication of IL164670A0 publication Critical patent/IL164670A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16467004A 2002-04-26 2004-10-18 Pharmaceutical compositions containing growth hormone and an insulin sensitizing agent IL164670A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0209642A GB0209642D0 (en) 2002-04-26 2002-04-26 Metabolic syndrome
GB0218912A GB0218912D0 (en) 2002-08-14 2002-08-14 Metabolic syndrome
PCT/EP2003/004357 WO2003090784A1 (en) 2002-04-26 2003-04-24 Treatment of metabolic syndrome

Publications (1)

Publication Number Publication Date
IL164670A0 true IL164670A0 (en) 2005-12-18

Family

ID=29272006

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16467004A IL164670A0 (en) 2002-04-26 2004-10-18 Pharmaceutical compositions containing growth hormone and an insulin sensitizing agent

Country Status (11)

Country Link
EP (1) EP1499357A1 (pt)
JP (1) JP2005523915A (pt)
KR (1) KR20040101545A (pt)
CN (1) CN1646167A (pt)
AU (1) AU2003227683A1 (pt)
BR (1) BR0309375A (pt)
CA (1) CA2483005A1 (pt)
IL (1) IL164670A0 (pt)
MX (1) MXPA04010544A (pt)
PL (1) PL372900A1 (pt)
WO (1) WO2003090784A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10231976B2 (en) * 2010-02-08 2019-03-19 Prairie Pharmaceuticals LLC Methods for the use of progestogen as a glucocorticoid sensitizer

Also Published As

Publication number Publication date
MXPA04010544A (es) 2005-08-16
JP2005523915A (ja) 2005-08-11
PL372900A1 (en) 2005-08-08
KR20040101545A (ko) 2004-12-02
BR0309375A (pt) 2005-03-29
AU2003227683A1 (en) 2003-11-10
CA2483005A1 (en) 2003-11-06
WO2003090784A1 (en) 2003-11-06
CN1646167A (zh) 2005-07-27
EP1499357A1 (en) 2005-01-26

Similar Documents

Publication Publication Date Title
HK1093975A1 (en) Ppar-activating compound and pharmaceutical composition containing same
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
AU2003266133A1 (en) Materials and methods for drug delivery and uptake
IL164209A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL166620A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
AU2003288994A1 (en) Nitrogen-containing heterocyclic compounds and medicinal use thereof
AU2003298841A1 (en) Pharmaceutical compositions containing indistinguishable drug components
AU2003291024A1 (en) Rhodanine derivatives and pharmaceutical compositions containing them
IL163117A (en) Indazole derivatives and pharmaceutical compositions containing the same
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
IL178297A0 (en) Hydrazide derivatives and pharmaceutical compositions containing the same
HK1077582A1 (en) Aryl 5-thio beta-d-glucopyranside derivatives and remedies for diabetes containing sthe same
IL163866A0 (en) 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient
AU2003243750A8 (en) Rapidly dissolving micro-perforator for drug delivery and other applications
EP1479666A4 (en) ESTER CONNECTION AND THEIR MEDICAL USE
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2003247942A1 (en) Device and method for drug delivery to animals
EP1577317A4 (en) NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, MEDICINAL COMPOSITIONS COMPRISING SAID DERIVATIVES AND MEDICAL USE OF SAID DERIVATIVES
IL197889A (en) Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same
HK1082677A1 (en) Androgen pharmaceutical composition and use for manufacture of medicament
AU2003279253A1 (en) Silicone blends and composites for drug delivery
IL174144A0 (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
IL163868A (en) Hemiasterlin derivatives and pharmaceutical compositions comprising them
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
PL361518A1 (en) Application of substance and pharmaceutical composition